BACKGROUND: The goal of the Prostate Cancer Biorepository Network (PCBN) is to develop a biorepository with high-quality, well-annotated specimens obtained in a systematic, reproducible fashion using optimized and standardized protocols, and an infrastructure to facilitate the growth of the resource and its wide usage by the prostate cancer research community. An emerging area of concern in the field of prostate cancer biobanking is an apparent shift in the proportion of surgical procedures performed for prostate cancer treatment from radical retropubic prostatectomy (RRP) to robot-assisted laparoscopic prostatectomy (RALP). Our study aimed to determine the potential impact of the RALP procedure on the detection of known prostate cancer biomarkers, and the subsequent suitability of RALP-derived specimens for prostate cancer biomarker studies. METHODS: DNA and RNA were extracted from RRP and RALP specimens. Quality assessment was conducted using spectrophotometric analysis and RNA was analyzed for RNA integrity number (RIN) and by real-time reverse-transcription PCR (qRT-PCR) for racemase, hepsin, ERG, TMPRSS2-ERG gene fusions, and the microRNAs miR-26a, miR-26b, miR-141, and miR-221. RESULTS: We demonstrate that extraction of derivatives from frozen tissues from RRP and RALP specimens yields samples of equally high quality as assessed by spectrophotometric and RIN analysis. Likewise, expression levels of genes analyzed by qRT-PCR did not differ between RRP and RALP-derived tissues. CONCLUSIONS: Our studies indicate that samples obtained from RALP specimens may be suitable for prostate cancer biomarker studies-an important finding given the current shift in surgical procedures for prostate cancer treatment.
BACKGROUND: The goal of the Prostate Cancer Biorepository Network (PCBN) is to develop a biorepository with high-quality, well-annotated specimens obtained in a systematic, reproducible fashion using optimized and standardized protocols, and an infrastructure to facilitate the growth of the resource and its wide usage by the prostate cancer research community. An emerging area of concern in the field of prostate cancer biobanking is an apparent shift in the proportion of surgical procedures performed for prostate cancer treatment from radical retropubic prostatectomy (RRP) to robot-assisted laparoscopic prostatectomy (RALP). Our study aimed to determine the potential impact of the RALP procedure on the detection of known prostate cancer biomarkers, and the subsequent suitability of RALP-derived specimens for prostate cancer biomarker studies. METHODS: DNA and RNA were extracted from RRP and RALP specimens. Quality assessment was conducted using spectrophotometric analysis and RNA was analyzed for RNA integrity number (RIN) and by real-time reverse-transcription PCR (qRT-PCR) for racemase, hepsin, ERG, TMPRSS2-ERG gene fusions, and the microRNAs miR-26a, miR-26b, miR-141, and miR-221. RESULTS: We demonstrate that extraction of derivatives from frozen tissues from RRP and RALP specimens yields samples of equally high quality as assessed by spectrophotometric and RIN analysis. Likewise, expression levels of genes analyzed by qRT-PCR did not differ between RRP and RALP-derived tissues. CONCLUSIONS: Our studies indicate that samples obtained from RALP specimens may be suitable for prostate cancer biomarker studies-an important finding given the current shift in surgical procedures for prostate cancer treatment.
Authors: Michael Kerger; Matthew K H Hong; John Pedersen; Timothy Nottle; Andrew Ryan; John Mills; Justin S Peters; Daniel Moon; Helen Crowe; Anthony J Costello; Niall M Corcoran; Christopher M Hovens Journal: Pathology Date: 2012-04 Impact factor: 5.306
Authors: Hemamali Samaratunga; Rodolfo Montironi; Lawrence True; Jonathan I Epstein; David F Griffiths; Peter A Humphrey; Theo van der Kwast; Thomas M Wheeler; John R Srigley; Brett Delahunt; Lars Egevad Journal: Mod Pathol Date: 2010-09-10 Impact factor: 7.842
Authors: Jason C Gonzales; Louis M Fink; Oscar B Goodman; James T Symanowski; Nicholas J Vogelzang; David C Ward Journal: Clin Genitourin Cancer Date: 2011-07-01 Impact factor: 2.872
Authors: Raquel Esgueva; Kyung Park; Robert Kim; Naoki Kitabayashi; Christopher E Barbieri; Philip J Dorsey; Cyril Abraham; Samprit Banerjee; Robert A Leung; Ashutosh K Tewari; Stéphane Terry; Maria M Shevchuk; David S Rickman; Mark A Rubin Journal: Diagn Mol Pathol Date: 2012-06
Authors: Kati K Waltering; Kati P Porkka; Sanni E Jalava; Alfonso Urbanucci; Pekka J Kohonen; Leena M Latonen; Olli P Kallioniemi; Guido Jenster; Tapio Visakorpi Journal: Prostate Date: 2010-10-13 Impact factor: 4.104
Authors: R J Bryant; T Pawlowski; J W F Catto; G Marsden; R L Vessella; B Rhees; C Kuslich; T Visakorpi; F C Hamdy Journal: Br J Cancer Date: 2012-01-12 Impact factor: 7.640
Authors: Shu-Han Yu; Qizhi Zheng; David Esopi; Anne Macgregor-Das; Jun Luo; Emmanuel S Antonarakis; Charles G Drake; Robert Vessella; Colm Morrissey; Angelo M De Marzo; Karen S Sfanos Journal: Cancer Immunol Res Date: 2015-06-05 Impact factor: 11.151
Authors: Qizhi Zheng; Sarah B Peskoe; Judit Ribas; Fatema Rafiqi; Tarana Kudrolli; Alan K Meeker; Angelo M De Marzo; Elizabeth A Platz; Shawn E Lupold Journal: Prostate Date: 2014-09-22 Impact factor: 4.104
Authors: Javier A Baena-Del Valle; Qizhi Zheng; David M Esopi; Michael Rubenstein; Gretchen K Hubbard; Maria C Moncaliano; Andrew Hruszkewycz; Ajay Vaghasia; Srinivasan Yegnasubramanian; Sarah J Wheelan; Alan K Meeker; Christopher M Heaphy; Mindy K Graham; Angelo M De Marzo Journal: J Pathol Date: 2017-11-14 Impact factor: 7.996
Authors: David R Wise; Jeffrey A Schneider; Joshua Armenia; Victor Adorno Febles; Bridget McLaughlin; Ryan Brennan; Katie L Thoren; Wassim Abida; Karen S Sfanos; Angelo M De Marzo; Srinivasan Yegnasubramanian; Josef J Fox; Michael Haas; Heidi Heath; Michael H Kagey; Walter Newman; Cynthia A Sirard; Martin Fleisher; Michael J Morris; Yu Chen; Steven M Larson; Michael C Haffner; Peter S Nelson; Nikolaus Schultz; Michael J Garabedian; Howard I Scher; Susan K Logan; Charles L Sawyers Journal: JCO Precis Oncol Date: 2020-09-29